Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Scleroderma
•
Nephrology
•
End stage kidney disease
Would you avoid fistula placement in patients with ESKD secondary to scleroderma?
Answer from: at Community Practice
I do not have any direct experience with this, but I would be very reluctant to place a fistula in someone with scleroderma.
Sign In
or
Register
to read more
30550
Related Questions
How can narrative medicine be used to potentially improve outcomes for patients on dialysis?
Would you use argatroban or citrate catheter lock in a patient with ESKD and HITT?
How do you use NT-proBNP in patients with chronic kidney disease or end-stage kidney disease, given that these conditions can affect NT-proBNP levels?
Do you recommend avoiding morphine in patients with ESKD?
What is your approach to managing ESKD patients who are disruptive and threatening in the dialysis unit?
How would you approach managing a patient with ESKD on peritoneal dialysis who has a milky appearance of peritoneal effluent but low peritoneal fluid triglyceride levels?
Do you have a preference between midodrine and droxidopa for patients with ESKD who experience intradialytic hypotension?
What are your top takeaways from ASN Kidney Week 2025?
How do you modify the hemoglobin goal and ESA dosing for patients with sickle cell anemia and ESKD on hemodialysis?
Would you consider not returning the blood from the dialysis circuit as a strategy for managing polycythemia in a patient with ESKD on hemodialysis who has a hemoglobin level greater than 16 g/dL?